Lupus Market is anticipated to have held a market value of USD 1.48 billion in the year 2017 and is expected to grow at a CAGR of 11.2% during the forecast period.
Lupus Market Outlook
Lupus is an autoimmune disease in which the immune system produces antibodies that attack the body’s healthy tissue. The antibodies produced by the immune system in lupus cause inflammation, tissue damage, and pain.
Lupus is a systemic autoimmune disease that causes inflammation throughout the body. In patients with lupus, the immune system attacks healthy cells and tissues of the body which can result in damage to many parts of the body including the skin, joints, kidney, heart, lungs, blood vessels, and brain.
Key Players
Some of the prominent players in the global lupus market are Aurinia Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Cadila Healthcare, GlaxoSmithKline plc, Mylan N.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Sanofi, Lycera Corporation, Eli Lily and Company, and Merck KGaA.
Avail Sample Copy@ https://www.marketresearchfuture.com/sample_request/6636
Segmentation
The Global Lupus Market has been segmented into type, treatment, and end user. The global market, by types, has been segmented into systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, and neonatal lupus. The systemic lupus erythematosus segment is expected to hold the largest market share owing to the growing prevalence and increasing drug development in recent years.
On the basis of treatment, the global market has been segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, corticosteroids, immunosuppressants, biologics, and other.
On the basis of end user, the global market has been segmented into hospital & clinics, diagnostic laboratories, and others.
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Browse Complete Premium Research@ https://www.marketresearchfuture.com/reports/lupus-market-6636
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
…Continued
Many companies are engaged in the global lupus market. The prominent players in the market are engaged in strategic collaborations, and new product launches to strengthen their market position. For instance, in January, Sanofi and ImmuNext agreed to develop treatments for autoimmune diseases including multiple sclerosis and lupus.
Regional Market Summary
Geographically, the Americas is expected to dominate the global market owing to the presence of well-developed healthcare sector, rising demand for better treatment options, growing prevalence of lupus, government initiatives for lupus, and availability of reimbursement. Europe is expected to hold the second largest position in the global lupus market owing to the increasing number of research and development activities and the rising prevalence of lupus in the region. Asia-Pacific region is anticipated to be the fastest growing region owing to the growing prevalence of lupus, continuously growing healthcare sector and increasing regional expansion by prominent market players. The Middle East & Africa has the lowest share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector.
Majority of the patients affected by lupus are women, and the majority of the people develop lupus between 15 to 45 years of age. The growing prevalence of lupus, ongoing medical advancements in the treatment of systemic lupus erythematosus, rising research and development activities are some factors that are expected to propel the market growth during the assessment period. On the other hand, the factors such as strict government regulation and increasing prices of lupus drugs may hinder the market growth over the assessment period.
Inquire for Discount@ https://www.marketresearchfuture.com/check-discount/6636
Intended Audience
- Research and consulting firmsPharmaceutical and biotechnology manufacturers
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Your information will never be shared with any third party.